Covid steaming fad leads to rise in cases of burns

MUMBAI: The misconception that steam inhalation can inhibit or kill the virus causing Covid-19 has led to a crisis of another kind: a significant increase in steam inhalation related scald burns both in children and adults. Some hospitals have seen between three to ten-fold rise in scald burns since May. Accidental spillage of hot water while trying to take steam from an open vessel has been found to be the most common cause for such burns. In many cases, people have sustained up to 20% burns, at times requiring hospitalization for dressing under anaesthesia, according to doctors. In most cases, the burn victims were either themselves suffering from Covid-19 or someone in the family was. The recovery took a minimum of 14 days. Doctors at the Bombay Hospital in Marine Lines have treated seven instances of scalds in the last three months. ....read more

Japan Experience of COVID-19

Japans approach of busting the COVID clusters appears to be nearing its limit, amid a rise in cases. Join us today for a discussion on Japans experience of COVID-19 with Dr Marie Uzawa Urabe, President of Uzawa Kokusai Gakkan, on MEDtalks with Dr K K Aggarwal COVID edition, at 7:00 PM.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

CMAAO Coronavirus Facts and Myth Buster: COVID-19 at Geneva Headquarters

With input from Dr Monica Vasudev 1152: When lab personnel process COVID-19 tests, there is a slight risk that the paper forms accompanying the specimens can be contaminated with the virus. Researchers at the Birmingham Public Health Laboratory in the UK assessed randomly selected paper forms and specimen packaging when the team was processing nearly 700 COVID-19 tests daily. Of the 37 items tested, one piece of paperwork was found to carry genetic material from the coronavirus. The form had come from a low-risk hospital ward, and the specimen from the patient was negative for the coronavirus, thus pointing to contamination, the researchers wrote in the Journal of Hospital Infection, calling for strict laboratory practices, including hand hygiene, appropriate personal protective equipment as well as the use of electronic test requesting wherever possible. ....read more

CMAAO Coronavirus Facts and Myth Buster: COVID-19 Home Kit, POC

With input from Dr Monica Vasudev1155: First Rapid At-Home COVID Test: The US FDA has issued an EUA for the first at-home COVID-19 test, which provides results within 30 minutes. The All-In-One Test Kit is a molecular, single-use test that detects SARS-CoV-2 with the help of self-collected nasal swab samples among people aged 14 years and older. The test has also been authorized for use in doctors offices, hospitals, urgent care centers, and emergency departments for patients of all ages. The samples need to be collected by a healthcare provider when the test is used in these care settings for patients below 14 years of age. ....read more

Man Vachan Kaya

Man,vachan, kaya are the three fundamental principles used to define non-violence (ahimsa) and truthfulness (satya). Being truthful means whatever you are thinking, speaking and doing, it is the same. You should be one in whatever you think, do or speak. Ahimsa is the fundamental principle of Jainism, which means you should be non-violent not only in your actions but also in your speech and thoughts. Being truthful makes you Satyugi. ....read more

Video of The day

Which vaccine should I choose?

Healthcare News Monitor

Covid-19 vaccination programme to be examined by parliamentary committee

livemint

NEW DELHI: The ambitious adult vaccination programme for Covid being finalised by the National Democratic Alliance (NDA) government is likely to come under discussion and scrutiny by a parliamentary committee. This will be the first time India will try to administer a vaccine to a large section of population. As the office of Prime Minister Narendra Modi gears up for one of its largest adult vaccination programmes for covid-19 pandemic in the world, its production will be discussed by the standing committee on chemicals and fertilizers is holding a meeting on Monday to get representation from officials of Department of Pharmaceuticals on the ‘status of covid-19 vaccine production in India’.

Covid-19: Indias Top Doctors On How To Treat It

ndtv.com

What Happens When There Is No Known Treatment Available? Recall the last time you had fever and cough and visited a doctor. It was probably a ten- or fifteen-minute interaction, during which the doctor would have advised you to take rest and drink plenty of water. The doctor may also have prescribed a few pills (not necessarily an antibiotic) to reduce the symptoms. It is also possible that if you had an illness which may have been spread by coughing and sneezing, the doctor would have advised you to cover your mouth while coughing. No matter which part of the country (or world) you are in, it is likely that you would be provided a similar course of treatment, with minor variations. A standardized approach is how medical science functions and it is backed by current evidence on how best to manage such a clinical situation.

Indian pharma industry: Backbone of Indian economy in the current pandemic

expresspharma.in

In the current pandemic (COVID-19) where India’s GDP has shrunk by 23.9 per cent in Q1 of the current fiscal, some of the sectors keeping the country alive is healthcare and pharma besides agriculture. The Indian pharma industry is known as ‘the pharmacy of the world’ as it is a leading supplier in generics with one of the highest numbers of USFDA approved plants. According to IKON Marketing Consultants’s estimates, in the current fiscal, 2020-21 the Indian pharma industry is estimated to be worth $43 billion. Let’s have a look at how it is contributing during the current pandemic towards the health of our economy and check its pulse on different parameters.

Indian-American doctor identifies possible COVID-19 treatment

thehindu.com

An Indian-American scientist has discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ failure in patients diagnosed with COVID-19. Published online in the journal Cell, the research coming from the lab of Dr. Thirumala-Devi Kanneganti, an Indian-born researcher working at St. Jude Children’s Research Hospital in Tennessee, identified the drugs after discovering that the hyperinflammatory immune response associated with COVID-19 leads to tissue damage and multi-organ failure in mice by triggering inflammatory cell death pathways.